Resistance to Apoptosis and Up Regulation of Bcl-2 In Benign Prostatic Hyperplasia After Androgen Deprivation (original) (raw)
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
Mark Day
Cancer research, 1995
View PDFchevron_right
Bcl-2 Protein Expression Correlates with Cell Survival and Androgen Independence in Rat Prostatic Lobes
Terry Brown
Endocrinology, 2002
View PDFchevron_right
Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer
Ming-fong Lin
Prostate Cancer and Prostatic Diseases, 2002
View PDFchevron_right
An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis
Harris Perlman, Ralph Buttyan
Cell Death and Differentiation, 1999
View PDFchevron_right
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer
Elda Perlino
International journal of oncology, 2011
View PDFchevron_right
Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells
M. Bosseler, Guy Berchem
Cancer research, 1995
View PDFchevron_right
Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS and Buttyan ROverexpression of Bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55: 4438-4445
Harris Perlman, Ralph Buttyan, Anthony Raffo
Cancer Research
View PDFchevron_right
Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia
Cristiana Angelucci
Anticancer research
View PDFchevron_right
Androgen signaling and post-transcriptional downregulation of Bcl-2 in androgen-unresponsive prostate cancer
Velliyur Gopalakrishnan
Prostate Cancer and Prostatic Diseases, 2004
View PDFchevron_right
Immunohistochemical Study Of Bcl-2 Protein And Estrogen Receptor-Alpha Expression In Benign Prostatic Hyperplasia And Prostatic Carcinoma
Ali Emad
The Egyptian Journal of Hospital Medicine, 2004
View PDFchevron_right
Suppression of default apoptosis in androgen‐dependent cells by testosterone‐mediated bcl‐2 expression
Masahiro Iida
International Journal of Urology, 1999
View PDFchevron_right
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia
Antonio Micali
International journal of molecular sciences, 2016
View PDFchevron_right
Homeostasis: apoptosis and cell cycle in normal and pathological prostate
Mar Royuela
The aging male : the official journal of the International Society for the Study of the Aging Male, 2018
View PDFchevron_right
The expression of androgen-responsive genes is Up-Regulated in the epithelia of benign prostatic hyperplasia
Katherine J O'Malley
The Prostate, 2009
View PDFchevron_right
The effect of androgen deprivation on malignant and benign prostate tissue
Marvin Rubenstein
Medical Oncology, 1997
View PDFchevron_right
THE PROGNOSTIC VALUE OF PRETREATMENT EXPRESSION OF ANDROGEN RECEPTOR AND BCL-2 IN HORMONALLY TREATED PROSTATE CANCER PATIENTS
Theodorus Van Der Kwast
The Journal of Urology, 1997
View PDFchevron_right
Androgen blocks apoptosis of hormone-dependent prostate cancer cells
Edward Gelmann
Cancer research, 2001
View PDFchevron_right
Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression
Stan Svojanovsky
The Prostate, 2008
View PDFchevron_right
Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy
Kyriakos Revelos
Anticancer research
View PDFchevron_right
Bag-1 Expression in Hyperplastic and Neoplastic Prostate Tissue: Is There Any Relationship with BCL-Related Proteins and Androgen Receptor Status?
Pınar Atasoy
Tumori Journal, 2005
View PDFchevron_right
Immunohistochemical analysis of the extrinsic apoptosis process in the non-neoplastic and neoplastic prostate
Alev Deresoy
Turkish Journal of Pathology
View PDFchevron_right
Early effects of pharmacological androgen deprivation in human prostate cancer
Shomik Sengupta
BJU International, 2007
View PDFchevron_right
Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention
Khurram Chaudhary
Environmental Health Perspectives, 1999
View PDFchevron_right
Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle
Ralph Buttyan
Cancer research, 1992
View PDFchevron_right
Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer
Ahmad Monabati
Pathology & Oncology Research, 2004
View PDFchevron_right
Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage
Jialing Xiang
Cell Research, 2007
View PDFchevron_right
Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
Vesna Janevska
Open Access Macedonian Journal of Medical Sciences
View PDFchevron_right
Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
Jovo Bogdanovic
Vojnosanitetski pregled
View PDFchevron_right
A Novel Gene Overexpressed in the Prostate of Castrated Rats: Hormonal Regulation, Relationship to Apoptosis and to Acquired Prostatic Cell Androgen Independence1
Benoit Hennuy
Endocrinology, 1999
View PDFchevron_right
To Die or to Survive, a Fatal Question for the Destiny of Prostate Cancer Cells after Androgen Deprivation Therapy
William Jia
Cancers, 2011
View PDFchevron_right
Effect of Bcl-2 overexpression in human prostate cancer cells in vitro and in vivo
Tadao Kakizoe
International Journal of Urology, 1999
View PDFchevron_right
Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02
Seth Rosenthal
Clinical Cancer Research, 2007
View PDFchevron_right
bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer
Janice Royds
British journal of cancer, 1996
View PDFchevron_right